BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34192575)

  • 1. COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
    Fekkar A; Neofytos D; Nguyen MH; Clancy CJ; Kontoyiannis DP; Lamoth F
    Clin Microbiol Infect; 2021 Sep; 27(9):1376-1378. PubMed ID: 34192575
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
    Lamoth F; Glampedakis E; Boillat-Blanco N; Oddo M; Pagani JL
    Clin Microbiol Infect; 2020 Dec; 26(12):1706-1708. PubMed ID: 32659385
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Associated Pulmonary Aspergillosis: A Case Series.
    Yulianti M; Johan C; Tenda ED; Singh G; Herikurniawan H; Wijaya IPEK
    Acta Med Indones; 2022 Apr; 54(2):292-298. PubMed ID: 35818652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 associated with pulmonary aspergillosis: A literature review.
    Lai CC; Yu WL
    J Microbiol Immunol Infect; 2021 Feb; 54(1):46-53. PubMed ID: 33012653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.
    Armstrong-James D; Youngs J; Bicanic T; Abdolrasouli A; Denning DW; Johnson E; Mehra V; Pagliuca T; Patel B; Rhodes J; Schelenz S; Shah A; van de Veerdonk FL; Verweij PE; White PL; Fisher MC
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32703771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
    Bartoletti M; Pascale R; Cricca M; Rinaldi M; Maccaro A; Bussini L; Fornaro G; Tonetti T; Pizzilli G; Francalanci E; Giuntoli L; Rubin A; Moroni A; Ambretti S; Trapani F; Vatamanu O; Ranieri VM; Castelli A; Baiocchi M; Lewis R; Giannella M; Viale P;
    Clin Infect Dis; 2021 Dec; 73(11):e3606-e3614. PubMed ID: 32719848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes.
    de Almeida JN; Doi AM; Watanabe MJL; Maluf MM; Calderon CL; Silva M; Pasternak J; Koga PCM; Santiago KAS; Aranha LFC; Szarf G; da Silva Teles GB; Filippi RZ; Paes VR; Baeta M; Hamerschlak N; Mangueira CLP; Martino MDV
    Mycoses; 2022 Apr; 65(4):449-457. PubMed ID: 35174567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
    Chong WH; Neu KP
    J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed mold infection with
    Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
    Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
    Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
    Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
    Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive pulmonary aspergillosis complicating SARS-CoV-2 pneumonia: A diagnostic challenge.
    Antinori S; Rech R; Galimberti L; Castelli A; Angeli E; Fossali T; Bernasconi D; Covizzi A; Bonazzetti C; Torre A; Carsana L; Tonello C; Zerbi P; Nebuloni M
    Travel Med Infect Dis; 2020; 38():101752. PubMed ID: 32470620
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
    Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
    J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.
    Alanio A; Dellière S; Fodil S; Bretagne S; Mégarbane B
    Lancet Respir Med; 2020 Jun; 8(6):e48-e49. PubMed ID: 32445626
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Mitaka H; Kuno T; Takagi H; Patrawalla P
    Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges.
    Prattes J; Koehler P; Hoenigl M;
    Intensive Care Med; 2021 Nov; 47(11):1339-1340. PubMed ID: 34468820
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Singh S; Verma N; Kanaujia R; Chakrabarti A; Rudramurthy SM
    Mycoses; 2021 Sep; 64(9):1015-1027. PubMed ID: 34057252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus.
    Shadrach BJ; Goel R; Deokar K; Jain A
    Monaldi Arch Chest Dis; 2021 Apr; 91(2):. PubMed ID: 33849262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.